Systemic hydrocortisone to prevent bronchopulmonary dysplasia in preterm infants (the SToP-BPD study); a multicenter randomized placebo controlled trial

BACKGROUND: Randomized controlled trials have shown that treatment of chronically ventilated preterm infants after the first week of life with dexamethasone reduces the incidence of the combined outcome death or bronchopulmonary dysplasia (BPD). However, there are concerns that dexamethasone may inc...

Descripción completa

Detalles Bibliográficos
Autores principales: Onland, Wes, Offringa, Martin, Cools, Filip, De Jaegere, Anne P, Rademaker, Karin, Blom, Henry, Cavatorta, Eric, Debeer, Anne, Dijk, Peter H, van Heijst, Arno F, Kramer, Boris W, Kroon, Andre A, Mohns, Thilo, van Straaten, Henrica L, te Pas, Arjan B, Theyskens, Claire, van Weissenbruch, Mirjam M, van Kaam, Anton H
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2011
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3245429/
https://www.ncbi.nlm.nih.gov/pubmed/22070744
http://dx.doi.org/10.1186/1471-2431-11-102

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3245429/
https://www.ncbi.nlm.nih.gov/pubmed/22070744
http://dx.doi.org/10.1186/1471-2431-11-102

Ejemplares similares